Who
June Bray
Director
Company insider
Files Form 4 as: Director, BioXcel Therapeutics; Director, Quince Therapeutics.
In numbers
- Trades disclosed
- 14
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 1 Mar 2021
- Last trade
- 9 Jan 2026
- Last filed
- 21 Jan 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 9 Jan 2026filed 12 Jan 2026 | BioXcel Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —17,000 at $0.00 | filing |
| 9 Jan 2026filed 12 Jan 2026 | BioXcel Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —17,000 at $0.00 | filing |
| 2 Jan 2026filed 21 Jan 2026 | Quince Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —18,724 at $0.00 | filing |
| 2 Jan 2026filed 21 Jan 2026 | Quince Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —18,724 at $0.00 | filing |
| 4 Jun 2025filed 6 Jun 2025 | Quince Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —27,000 at $0.00 | filing |
| 2 Jan 2025filed 8 Jan 2025 | Quince Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —30,282 at $0.00 | filing |
| 10 Jun 2024filed 11 Jun 2024 | BioXcel Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —17,000 at $0.00 | filing |
| 5 Jun 2024filed 7 Jun 2024 | Quince Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —27,000 at $0.00 | filing |
| 26 Jun 2023filed 28 Jun 2023 | BioXcel Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —17,000 at $0.00 | filing |
| 24 May 2023filed 26 May 2023 | Quince Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —27,000 at $0.00 | filing |
| 9 Jun 2022filed 10 Jun 2022 | IRLA IRulya Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —54,000 at $0.00 | filing |
| 19 May 2022filed 23 May 2022 | BioXcel Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —17,000 at $0.00 | filing |
| 11 Jun 2021filed 15 Jun 2021 | BioXcel Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 1 Mar 2021filed 3 Mar 2021 | BioXcel Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —4,167 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.